FY2025 · ended Dec 31, 2025 · Revenue $83.81M, +14.4% YoY · Filed Mar 6, 2026
Iradimed Corporation (IRMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $83.8 million and net income of $22.5 million. Free cash flow was $17.2 million.
Revenue (TTM)
$89.34M
+11.0% vs year-ago TTM
Net income (TTM)
$23.98M
+13.2% vs year-ago TTM
Operating cash flow (TTM)
$27.15M
+8.5% vs year-ago TTM
Free cash flow (TTM)
$26.14M
+77.2% vs year-ago TTM
EPS (TTM)
$1.86
+12.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
12.78M
+0.5% vs prior year
Net cash
$52.08M
FY 2024
Operating margin
32.3%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IRMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Orlando, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1325618
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $83.8M | $73.2M | $65.6M | $53.3M | $41.8M |
| Operating income | $26.1M | $22.0M | $20.0M | $15.6M | $9.8M |
| Net income | $22.5M | $19.2M | $17.2M | $12.8M | $9.3M |
| Diluted EPS | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 |
| Operating cash flow | $24.9M | $25.6M | $13.5M | $10.0M | $11.3M |
| Free cash flow | $17.2M | $17.6M | $6.0M | $9.2M | $10.8M |
| Total assets | $108.8M | $98.3M | $92.2M | $85.5M | $82.9M |
| Total liabilities | $14.2M | $11.5M | $20.7M | $11.8M | $10.7M |
| Stockholders' equity | $94.6M | $86.8M | $71.4M | $73.7M | $72.2M |
| Cash and investments | $51.2M | $52.2M | $49.8M | $58.0M | $62.0M |
| Total debt | — | $154,688 | $2.0M | $2.6M | $2.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 18, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
All 777 Iradimed Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.